VIRTTU BIOLOGICS
Virttu is a privately held biotechnology company, which has pioneered the development of oncolytic viruses for treating cancer.
VIRTTU BIOLOGICS
Industry:
Biotechnology Health Care
Founded:
1999-01-01
Address:
Leeds, Leeds, United Kingdom
Country:
United Kingdom
Website Url:
http://www.virttu.com
Status:
Active
Contact:
+441414451716
Email Addresses:
[email protected]
Technology used in webpage:
Network Solutions DNS
Similar Organizations
Epixis
Epixis SA, a biotechnology company, engages in the development of advanced immuno-therapies based on recombinant virus-like particles
Mucosis
Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.
UbiVac
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer.
Vacthera BioTech
Vacthera is a biotechnology company developing influenza virus based vaccines and cancer immuno therapies
Current Employees Featured
Official Site Inspections
http://www.virttu.com
- Host name: oil-fw-a.positive-dedicated.net
- IP address: 80.87.128.147
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Virttu Biologics"
Virttu Biologics - Crunchbase Company Profile & Funding
Virttu is a privately held biotechnology company, which has pioneered the development of oncolytic viruses for treating cancer.See details»
Virttu Biologics Company Profile 2024: Valuation, Investors ...
Developer of oncolytic virus therapy designed for the treatment of cancer. The company develops an immunotherapy product based on the Herpes Simplex Virus (HSV-1) that is designed to …See details»
Virttu Biologics (fka Crusade Laboratories) - VentureRadar
Website: http://www.virttu.com/ VIRTTU Biologics is a clinical stage biotechnology company pioneering the development of viruses to treat cancer. By remodeling a common virus we have …See details»
Virttu Biologics Company Profile - Office Locations ... - Craft
Virttu Biologics is a company committed to developing oncolytic immunotherapy and cancer viral treatment. Its main product is Seprehvir (HSV1716) derived from a modified version of the …See details»
Sorrento Therapeutics Announces Closing of its Acquisition of …
Apr 28, 2017 · Virttu's lead product candidate Seprehvir® (HSV1716) is derived from a modified version of the common human herpes simplex virus (HSV-1). Seprehvir® has been designed …See details»
Virttu Biologics - Products, Competitors, Financials, Employees ...
Virttu Biologics privately-held biotechnology company focused on the development of oncolytic virus therapy for treatment of cancer. Use the CB Insights Platform to explore Virttu Biologics's …See details»
Sorrento’s TNK Therapeutics Subsidiary to Acquire Virttu Biologics
Sorrento Therapeutics, Inc. Virttu, based in Glasgow, Scotland, is a privately-held biopharmaceutical company focused on the development of oncolytic virus therapy for …See details»
Sorrento's Cell Therapy Subsidiary Acquires Virttu
Apr 28, 2017 · Virttu, based in Glasgow, Scotland, is a privately-held biopharmaceutical company focused on the development of oncolytic virus therapy for the treatment of cancer. Virttu’s lead …See details»
Sorrento's TNK Therapeutics Subsidiary to Acquire Virttu Biologics
Nov 24, 2016 · TNK Therapeutics Inc ("TNK"), a subsidiary of Sorrento Therapeutics Inc has entered into a binding term sheet to acquire Virttu Biologics Limited ("Virttu"). Virttu, based in …See details»
Sorrento’s TNK Therapeutics Subsidiary to Acquire Virttu Biologics ...
Nov 28, 2017 · Virttu, based in Glasgow, Scotland, is a privately-held biopharmaceutical company focused on the development of oncolytic virus therapy for treatment of cancer.See details»
Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace
Biotech, Pharmaceutical and Clinical Research Jobs | BioSpaceSee details»
Bedell Cristin advises on sale of Virttu Biologics Limited
May 17, 2017 · Bedell Cristin has advised the Jersey-based majority shareholder of Virttu Biologics Limited (Virttu) on the sale of Virttu to TNK Therapeutics, Inc., a subsidiary of …See details»
Sorrento's TNK Therapeutics Subsidiary to Acquire Virttu Biologics
Nov 16, 2016 · Virttu, based in Glasgow, Scotland, is a privately-held biopharmaceutical company focused on the development of oncolytic virus therapy for treatment of cancer.See details»
Sorrento subsidiary to acquire Virttu Biologics
Nov 17, 2016 · Virttu's lead product candidate Seprehvir has completed phase 1 studies in Europe for treatment of solid tumors and is being evaluated in a phase 1/2a study in the U.K. …See details»
Virttu Biologics (fka Crusade Laboratories) | VentureRadar
VIRTTU Biologics is a clinical stage biotechnology company pioneering the development of viruses to treat cancer. By remodeling a common virus we have developed and patented a …See details»
| BioWorld
May 2, 2017 · Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, …See details»
Virttu Biologics (@virtualvirttu) / Twitter
Oct 9, 2012 · Virttu Biologics is committed to developing the next generation of oncolytic immunotherapy and deliver best in class cancer viral treatment. Nice article on oncolytic …See details»
What Is a Virtual Organization? With Benefits and Challenges
Aug 15, 2024 · A virtual organization is an operation where all members of the company work in different geographic locations while appearing as a single unit. It uses computers, software, …See details»
Data Encryption For Email & File Sharing | Virtru
Virtru's email encryption seamlessly integrates with Google Workspace and Microsoft Outlook, providing user-friendly, end-to-end protection for your messages and attachments.See details»